Q3 2021 Holdings
Filed 2021-11-15 | 33 holdings | $500.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Atea Pharmaceuticals Inc(AVIR) | COM | 04683R106 | $129.7M | 3,700,000 | 25.9% |
| Adagio Therapeutics Inc(IVVD) | COM | 00534A102 | $105.1M | 2,487,207 | 21.0% |
| Arcutis Biotherapeutics Inc.(ARQT) | COM | 03969K108 | $95.1M | 3,979,292 | 19.0% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $73.4M | 1,642,209 | 14.7% |
| Annexon Inc(ANNX) | COM | 03589W102 | $60.3M | 3,241,628 | 12.1% |
| Crinetics Pharmaceuticals(CRNX) | COM | 22663K107 | $35.4M | 1,679,701 | 7.1% |
| Springworks Therapeutics Inc | COM | 85205L107 | $306.5K | 4,831,307 | 0.1% |
| Dynavax Technologies Corp(DVAX) | COM NEW | 268158201 | $161.7K | 8,415,000 | 0.0% |
| Rapid Micro Biosystems Inc(RPID) | CLASS A COM | 75340L104 | $155.8K | 8,434,560 | 0.0% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $77.3K | 3,428,014 | 0.0% |
| Dicerna Pharmaceuticals Inc(DRNAUSD) | COM | 253031108 | $62.1K | 3,080,237 | 0.0% |
| Pharvaris N V(PHVS) | COM | N69605108 | $56.4K | 3,180,601 | 0.0% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $38.5K | 1,284,314 | 0.0% |
| Mersana Therapeutics Inc. | COM | 59045L106 | $34.9K | 3,695,667 | 0.0% |
| Syros Pharmaceuticals Inc | COM | 87184Q107 | $25.9K | 5,785,036 | 0.0% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $24.8K | 1,921,790 | 0.0% |
| Aeglea BIO Therapeutics Inc(AGLEUSD) | COM | 00773J103 | $22.6K | 2,847,689 | 0.0% |
| Aptinyx Inc | COM | 03836N103 | $20.8K | 8,891,758 | 0.0% |
| Solid Biosciences Inc | COM | 83422E105 | $19.0K | 7,929,918 | 0.0% |
| Marinus Pharmaceuticals Inc(MRNS*) | COM NEW | 56854Q200 | $16.3K | 1,431,058 | 0.0% |
| Savara Inc(SVRA) | COM | 805111101 | $16.0K | 11,622,598 | 0.0% |
| Nautilus Biotechnology Inc(NAUT) | COM | 63909J108 | $12.3K | 2,000,000 | 0.0% |
| X4 Pharmaceuticals Inc(ASNSUSD) | COM | 98420X103 | $11.2K | 2,119,540 | 0.0% |
| Research Alliance Corp II | COM CL A | 760873109 | $9.9K | 1,000,000 | 0.0% |
| Bluebird BIO Inc | COM | 09609G100 | $7.2K | 538,179 | 0.0% |
| Arya Sciences Acqu Corp IV | CL A | G31659108 | $7.0K | 700,000 | 0.0% |
| Arya Sciences Acquisitn Corp | CLASS A ORD SHS | G31658100 | $4.9K | 500,000 | 0.0% |
| Panacea Acquisition Corp II | CL A SHS | G6882C106 | $4.9K | 500,000 | 0.0% |
| Bcls Acquisition Corp | COM CL A | G0904B105 | $4.9K | 487,500 | 0.0% |
| Omega Alpha Spac | CL A | G6749V107 | $3.9K | 400,000 | 0.0% |
| Frazier Lifesciences Acqu Co | UNIT 12/09/2025 | G3710A121 | $3.0K | 300,000 | 0.0% |
| Jiya Acquisition Corp | COM CL A | 47760M102 | $2.9K | 300,000 | 0.0% |
| Helix Acquisition Corp | COM CL A | G4444C102 | $2.5K | 250,000 | 0.0% |